Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Magnetic Resonance Spectroscopy × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 27 Neoplasm Metastasis 21 Lung Neoplasms 21 Carcinoma, Non-Small-Cell Lung 19 Multiple Myeloma 15 Carcinoma, Renal Cell 15 Glioblastoma 14 Melanoma 13 Urinary Bladder Neoplasms 12 Triple Negative Breast Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 12 Ovarian Neoplasms 11 Mouth Neoplasms 11 Carcinoma 11 Breast Neoplasms 11 Oropharyngeal Neoplasms 10 Laryngeal Neoplasms 10 Glioma 10 Colorectal Neoplasms 10 Pancreatic Neoplasms 9 Lymphoma 9 Hypopharyngeal Neoplasms 9 Fallopian Tube Neoplasms 9 Carcinoma, Transitional Cell 9 Endometrial Neoplasms 8 Brain Neoplasms 8 Lymphoma, Large B-Cell, Diffuse 7 Leukemia, Myeloid, Acute 7 Burkitt Lymphoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡